Bispecific antibodies neutralize Sarbecoviruses with increased breadth and potency


In a recent study posted to the bioRxiv* preprint server, researchers developed bispecific antibodies (bsAbs), neutralizing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants.

First study of monkeypox infection in women provides new insights to inform public health response to ongoing outbreak

Previous article

A heavy burden of family financial stress from COVID on mental health of adolescents

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News